Concert: Baird's Health Care Conference (Concert Pharma) - Sep 5, 2014 - "CTP-499 Significantly Reduced Glycated Hemoglobin (HbA1c) Relative to Placebo Group"; "Phase 2 study was not designed as hypoglycemic study"; "Other diabetes medicines not controlled, No fasting glucose levels obtained, Mean baseline 0.4% higher for CTP-499 than placebo"
P2 data • Renal Disease
|